April 11, 2018
Currently, the main treatments for Alzheimer’s disease are drugs that increase levels of acetylcholine in the brain. The University of Bristol paper, published in Cell Reports, describes the role two main types of nicotinic receptor (α7 and α4β2 receptors) play in long-term memory retrieval and encoding – and the impact of […]
